Pilot study of the clinical and cognitive effects of high-frequency magnetic seizure therapy in major depressive disorder

Depression and Anxiety

Volumn 30, Issue 2, 2013, Pages 129-136

  Fitzgerald, Paul B ^a   Hoy, Kate E ^a   Herring, Sally E ^a   Clinton, Anne Maree ^b   Downey, Glenn ^b   Daskalakis, Zafiris J ^c  

^a Alfred and Monash University Central Clinical School ^*  (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

antidepressant; brain stimulation; cognitive; mood disorders; treatment

Indexed keywords

AGOMELATINE; ANALGESIC AGENT; BENZODIAZEPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; ELECTROSTIMULATION; FEMALE; FLUID RESUSCITATION; HEADACHE; HUMAN; LONG TERM CARE; MAGNETIC SEIZURE THERAPY; MAJOR DEPRESSION; MALE; MEMORY; OPEN STUDY; ORIENTATION; PILOT STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; THERAPY EFFECT; TREATMENT RESPONSE;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; SEIZURES; SEVERITY OF ILLNESS INDEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84872977967     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22005     Document Type: Article

References (51)

1. Fava M,. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53: 649-659. (Pubitemid 39658481)
2. Payne NA, Prudic J,. Electroconvulsive therapy: part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract 2009; 15: 346-368.
3. Rowny SB, Benzl K, Lisanby SH,. Translational development strategy for magnetic seizure therapy. Exp Neurol 2009; 219: 27-35.
4. Lisanby S,. Update on magnetic seizure therapy: a novel form of convulsive therapy. J ECT 2002; 18: 182-188. (Pubitemid 35471057)
5. Lisanby SH, Husain M, Morales O, et al. Controlled clinical trial of the antidepressant efficacy of magnetic seizure therapy in the treatment of major depression. ACNP Annu Meet Abstr 2003: 166.
6. Paillere Martinot ML, Galinowski A, Ringuenet D, et al. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsychopharmacology 2010; 13: 45-59.
7. Eranti S, Mogg A, Pluck G, et al. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007; 164: 73-81. (Pubitemid 46154785)
8. Fitzgerald PB, Huntsman S, Gunewardene R, et al. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int J Neuropsychopharmacol 2006; 9: 655-666. (Pubitemid 46122766)
9. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol 2006; 9: 641-654. (Pubitemid 46127397)
10. Lisanby SH, Luber B, Finck AD, et al. Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry 2001; 58: 199-200. (Pubitemid 32142758)
11. Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA,. Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001; 58: 303-305. (Pubitemid 32209685)
12. Kim SW, Grant JE, Rittberg BR, et al. Decreased memory loss associated with right unilateral ultra-brief pulse wave ECT. Minn Med 2007; 90: 34-35.
13. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J,. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy. J Affect Disord 2009; 116: 106-112.
14. Lisanby SH, Bulow P, Dwork AJ, Christensen JR, et al. Stereological and neuropathological examination of the safety of electroconvulsive shock (ECS) and magnetic seizure therapy (MST) in nonhuman primates. Biol Psychiatry 2005; 57: 147S.
15. Dwork AJ, Arango V, Underwood M, Ilievski B, et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry 2004; 161: 576-578. (Pubitemid 38326118)
16. Moscrip TD, Terrace HS, Sackeim HA, Lisanby SH,. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol 2006; 9: 1-11. (Pubitemid 43068329)
17. Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA,. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28: 1852-1865. (Pubitemid 41070851)
18. White PF, Amos Q, Zhang Y, et al. Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg 2006; 103: 76-80. (Pubitemid 44036035)
19. Wassermann EM,. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 1998; 108: 1-16.
20. Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res 2011; 45: 569-576.
21. Spellman T, McClintock SM, Terrace H, et al. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry 2008; 63: 1163-1170.
22. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20): 22-57.
23. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
24. Hamilton M,. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
25. Beck A, Ward C, Mendelson M, Mock J, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
26. Flemenbaum A, Zimmermann RL,. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 1973; 32: 783-792.
27. Parker G, Hadzi-Pavlovic D, editors. Melancholia: A Disorder of Movement and Mood. New York: Cambridge University Press; 1996.
28. Wechsler D,. Wechsler Test of Adult Reading. New York: The Psychological Corporation; 2001.
29. McElhiney M, Moody B, Sackeim H,. The Autobiographical Memory Interview-Short Form. New York State Psychiatric Institute: New York; 1997.
30. Lezak M,. Neuropsychological Assessment. 3rd ed. New York: Oxford University Press; 1995.
31. Benedict RH, Schretlen D, Groninger L, et al. Revision of the Brief Visuospatial Memory Test: studies of normal performance, reliability, and validity. Psychological Assessment 1996; 8: 145-153. (Pubitemid 26236038)
32. Sullivan K,. Alternate forms of prose passages for the assessment of auditory-verbal memory. Arch Clin Neuropsychol 2005; 20: 745-753. (Pubitemid 40984659)
33. Wechsler D,. Wechsler Memory Scale-Revised Manual. New York: Psychological Corporation; 1987.
34. Osterrieth PA,. Le test de copie d'une figure complexe. Arch Psychol 1944; 30: 206-356.
35. Wechsler D,. Wechsler Adult Intelligence Scale-Third Edition. San Antonio, TX: The Psychological Corporation; 1997.
36. Partington J, Leiter R,. Partington's pathway test. The Psychological Service Centre Bulletin 1949; 1: 9-20.
37. Golden C,. The Stroop Color and Word Test. Chicago, IL: Stoelting Company; 1978.
38. Spreen, O., Strauss, E. A., Compendium of Neuropsychological Tests, Edn. 2. New York: Oxford University Press; 1998.
39. Randolph C,. Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). San Antonio: Harcourt, TX: The Psychological Corporation; 1998.
40. Kirov G, Ebmeier KP, Scott AI, et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008; 193: 152-155.
41. Husain MM, Rush AJ, Fink M, Knapp R, et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. J Clin Psychiatry 2004; 65: 485-491.
42. Semkovska M, McLoughlin DM,. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychol 2010; 68 (6): 568-577.
43. Sackeim HA, Prudic J, Devanand DP, et al. A prospective, randomised, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different intensities. Arch Gen Psychiatry 2000; 57: 425-434. (Pubitemid 30257256)
44. O'Conner M, Lebowitz BK, Ly J, et al. A dissociation between anterograde and retrograde amnesia after treatment with electroconvulsive therapy: a naturalistic investigation. J ECT 2008; 24: 146-151.
45. Kho KH, VanVresswijk MF, Murre JMJ,. A retrospective controlled study into memory complaints reported by depressed patients after treatment with electroconvulsive therapy and pharmacotherapy or pharmacotherapy only. J ECT 2006; 22: 199-205. (Pubitemid 44379376)
46. Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007; 32: 244-254. (Pubitemid 44967804)
47. Lisanby SH, Maddox JH, Prudic J, et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch of Gen Psychiatry 2000; 57: 581-590. (Pubitemid 30349438)
48. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes. Arch Gen Psychiatry 2009; 66 (7): 729-737.
49. Kellner CH, Knapp R, Husain MM, et al. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry 2010; 196: 226-234.
50. Meeter M, Murre JMJ, Jassen SMJ, Birkenhager T,. Retrograde amnesia after electroconvulsive therapy: a temporary effect? J Affect Disord 2011; 132: 216-222.
51. Cycowicz YM, Luber B, Spellman T, Lisanby SH,. Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. J ECT 2009; 25: 157-164.